SPONSOR
Sunshine Lake Pharma Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2, Phase 2, Phase 3
Sunshine Lake Pharma Co., Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Acute Myeloid Leukemia, Adult, Depressive Disorder, Major.
The trial portfolio spans Phase 1, Phase 2, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Sunshine Lake Pharma Co., Ltd.
How many clinical trials has Sunshine Lake Pharma Co., Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Sunshine Lake Pharma Co., Ltd., of which 2 are actively recruiting participants. These trials cover conditions including Acute Myeloid Leukemia, Adult, Depressive Disorder, Major. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Sunshine Lake Pharma Co., Ltd. research focus on?
Sunshine Lake Pharma Co., Ltd. clinical trials span Acute Myeloid Leukemia, Adult, Depressive Disorder, Major. The research pipeline includes Phase 1, Phase 2, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Sunshine Lake Pharma Co., Ltd. clinical trial?
To participate in a Sunshine Lake Pharma Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Sunshine Lake Pharma Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Sunshine Lake Pharma Co., Ltd.
NCT05133882 Phase 1, Phase 2
Recruiting
A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML
Acute Myeloid Leukemia, Adult
NCT04984512 Phase 2, Phase 3
Recruiting
The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Disorder
Depressive Disorder, Major
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology